Ovid Therapeutics Inc. SEC filings OVID
Ovid Therapeutics Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 18, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Nov 7, 2025 | Dec 11, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 28, 2025 | Dec 11, 2025 |
| PREM14A | Filing | Oct 27, 2025 | Dec 11, 2025 |
| DEFA14A | Additional proxy material | May 22, 2025 | — |
| DEF 14A | Proxy statement | May 22, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | May 2, 2025 | Apr 24, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Apr 24, 2024 |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 8, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 9, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 10, 2021 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 4, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2019 | — |
| DEF 14A | Proxy statement | Apr 24, 2019 | Jun 7, 2019 |
| DEFA14A | Additional proxy material | Apr 24, 2018 | — |
| DEF 14A | Proxy statement | Apr 24, 2018 | Jun 6, 2018 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OVID (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1636651
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.